1. A young girl with severe polyarteritis nodosa successfully treated with tocilizumab: a case report.
- Author
-
Boistault M, Lopez Corbeto M, Quartier P, Berbel Arcobé L, Carsi Durall A, and Aeschlimann FA
- Subjects
- Child, Preschool, Female, Foot blood supply, Hand blood supply, Hand surgery, Humans, Polyarteritis Nodosa surgery, Antibodies, Monoclonal, Humanized therapeutic use, Polyarteritis Nodosa drug therapy
- Abstract
Background: Childhood Polyarteritis nodosa (PAN) is a systemic vasculitis with necrotizing inflammation of medium- and small-sized arteries. Disease evolution may be severe and refractory to standard treatment including prednisone, azathioprine and cyclophosphamide., Case Presentation: We present the case of a young girl with severe PAN resulting in progressive ischemia and necrosis of fingers and toes. Biological work-up revealed increased acute phase reactants and interleukin-6 levels. She was only partially controlled despite high-dose corticosteroids and cyclophosphamide infusions, and eventually achieved rapid improvement and sustained remission on tocilizumab. Further, we review the current evidence of the interleukin-6-inhibitor tocilizumab for the treatment of PAN., Conclusion: Tocilizumab may be an efficient therapeutic option in a subset of treatment-refractory children with PAN., (© 2021. The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF